Hantz Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$307K Sell
1,191
-41,285
-97% -$10.6M 0.01% 568
2025
Q1
$9.51M Sell
42,476
-1,658
-4% -$371K 0.17% 121
2024
Q4
$10.1M Sell
44,134
-1,134
-3% -$259K 0.18% 125
2024
Q3
$11.1M Sell
45,268
-1,341
-3% -$327K 0.2% 112
2024
Q2
$8.92M Sell
46,609
-999
-2% -$191K 0.17% 148
2024
Q1
$9.43M Sell
47,608
-2,340
-5% -$463K 0.18% 143
2023
Q4
$8.59M Buy
49,948
+1,352
+3% +$233K 0.19% 156
2023
Q3
$7.19M Sell
48,596
-2,730
-5% -$404K 0.18% 163
2023
Q2
$11.2M Buy
51,326
+188
+0.4% +$41.1K 0.28% 106
2023
Q1
$11.2M Buy
51,138
+861
+2% +$189K 0.31% 90
2022
Q4
$10.5M Buy
50,277
+902
+2% +$188K 0.32% 95
2022
Q3
$10.8M Buy
49,375
+216
+0.4% +$47.2K 0.37% 76
2022
Q2
$10.3M Buy
49,159
+596
+1% +$125K 0.35% 84
2022
Q1
$11.8M Buy
48,563
+2,810
+6% +$681K 0.35% 85
2021
Q4
$11.9M Buy
45,753
+2,658
+6% +$692K 0.34% 85
2021
Q3
$11.4M Buy
43,095
+4,900
+13% +$1.29M 0.37% 78
2021
Q2
$9.42M Buy
38,195
+1,316
+4% +$324K 0.35% 81
2021
Q1
$7.16M Buy
36,879
+1,298
+4% +$252K 0.3% 98
2020
Q4
$7.56M Buy
35,581
+558
+2% +$119K 0.34% 79
2020
Q3
$6M Buy
35,023
+642
+2% +$110K 0.31% 88
2020
Q2
$6.6M Sell
34,381
-7,029
-17% -$1.35M 0.37% 72
2020
Q1
$6.1M Buy
+41,410
New +$6.1M 0.42% 60